Challenges in personalised management of chronic diseases—heart failure as prominent example to advance the care process

Abstract

Chronic diseases are the leading causes of morbidity and mortality in Europe, accounting for more than 2/3 of all death causes and 75 % of the healthcare costs. Heart failure is one of the most prominent, prevalent and complex chronic conditions and is accompanied with multiple other chronic diseases. The current approach to care has important shortcomings with respect to diagnosis, treatment and care processes. A critical aspect of this situation is that interaction between stakeholders is limited and chronic diseases are usually addressed in isolation.Health care in Western countries requires an innovative approach to address chronic diseases to provide sustainability of care and to limit the excessive costs that may threaten the current systems. The increasing prevalence of chronic diseases combined with their enormous economic impact and the increasing shortage of healthcare providers are among the most critical threats. Attempts to solve these problems have failed, and future limitations in financial resources will result in much lower quality of care. Thus, changing the approach to care for chronic diseases is of utmost social importance.

Toward Integration of mHealth in Primary Care in the Netherlands: A Qualitative Analysis of Stakeholder Perspectives

“…Considering health system functioning and stakeholder views allowed for a comprehensive understanding of the mechanisms involved in mHealth integration. Moreover, the stakeholder analysis complemented this study by providing information on stakeholder interests and power which contributed to the development of a strategic view on future mHealth integration (28,58). Through member checking by discussing results in post-interviews, a validation step was added.…”

“…An inconvenient way to communicate with your doctor, I believe." (Patient 4, age58) However, this view was not shared among all end-users. Using mHealth services was also associated with perceived benefits, Frontiers in Public Health | www.frontiersin.org…”

Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016

“…The main reason for that is that the chronic disease stages, multifactorial diseases and comorbidities are not adequately addressed, since they do not follow the PPPM principles in currently practised health care systems [30]. An advanced CVD management is needed at both population and individual levels considering complex cardiovascular risk factors, co-morbidities, individualised patient profiles, optimised screening programmes and innovative preventive strategies.…”

“…Since its very beginning, EPMA is systematically working on the economy of PPPM that is pivotal for advancing health care on European and global scale [6, 8, 20–22, 28, 30, 35, 37, 40, 71, 72, 79–82]. …”

An injectable alginate/extra cellular matrix (ECM) hydrogel towards acellular treatment of heart failure

“…Since the mid 1990's enhanced coronary interventions have led to a decline in coronary heart disease mortality 1 . As a consequence of these treatments there has been an increase in chronic heart failure (HF) patient numbers 2 . As treatments for myocardial infarction (MI) continue to improve, it is predicted that the population of people suffering from HF will rise to 3% in Western societies by 2025 3 .…”